Shuttle Pharmaceuticals Holdings, Inc.(SHPH)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. SHPH is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of SHPH by reported 13-F value include CITADEL ADVISORS, BARCLAYS PLC, Tower Research Capital (TRC), based on the most recent SEC filings. SHPH trades on the Nasdaq exchange and files with the SEC under CIK 1757499. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SHPH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Shuttle Pharmaceuticals Holdings, Inc. directly from SEC EDGAR.

Net Income

$-2.2M

Institutions holding SHPH

Institutional investors reporting a position in Shuttle Pharmaceuticals Holdings, Inc. on SEC Form 13F.
InstitutionSharesValueReported
CITADEL ADVISORS24,354$79.2K2026-06-30
BARCLAYS PLC750$2.4K2026-06-30
Tower Research Capital (TRC)389$1.3K2026-06-30
KELLEHER FINANCIAL ADVISORS120$390.002026-06-30
HRT FINANCIAL78,597$255.002026-06-30
SHPH

Shuttle Pharmaceuticals Holdings, Inc.

SHPH
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q1 2026
EDGAR

$-2.15M

EPS (Diluted)

Q1 2026
EDGAR

$-0.43

Top Institutional Holders

as of Q2 2026
$83.5K total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…